Rockwell Medical, Inc.
USD0.57
-0.01 (-2.49%)
CEO
Mark Strobeck
IPO Date
1998-01-27
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$0.57
Prev. Close
$0.59
Day Low
$0.55
Day High
$0.58
52W Low
$0.55
52W High
$2.10
Market Cap
$0.02B
Volume
0.41M
| -132.0 |
| 31 Dec 2023 | FY | 10.4% | -10.1% | -39.6% | -16.2% | 0.63 | 1.73 | -5.2 |
| 31 Dec 2022 | FY | 5.6% | -25.7% | -132.4% | -40.1% | 1.16 | 2.00 | -0.5 |
| 31 Dec 2021 | FY | -3.9% | -52.8% | -1288.9% | -67.3% | 11.40 | 1.68 | -1.2 |
| 31 Dec 2020 | FY | 4.4% | -49.7% | -90.4% | -39.7% | 0.70 | 5.43 | -2.5 |
| 31 Dec 2019 | FY | 4.6% | -55.7% | -168.0% | -77.0% | 0.20 | 2.98 | -4.4 |
| 31 Dec 2018 | FY | -2.5% | -50.7% | -117.8% | -61.1% | 0.00 | 3.55 | -3.7 |
| 31 Dec 2017 | FY | 6.5% | -45.2% | -78.8% | -44.1% | 0.00 | 5.34 | -11.4 |
| 31 Dec 2016 | FY | 12.7% | -37.2% | -37.4% | -23.8% | 0.00 | 7.74 | -16.8 |
| -14.8 |
| 30 Sept 2025 | Q3 | 14.3% | -11.0% | -4.7% | -3.0% | 0.35 | 3.92 | -6.2 |
| 30 Jun 2025 | Q2 | 15.6% | -9.3% | -4.9% | -2.8% | 0.46 | 2.89 | -4.9 |
| 31 Mar 2025 | Q1 | 16.1% | -8.0% | -4.8% | -2.8% | 0.41 | 2.95 | -6.4 |
| 31 Dec 2024 | Q4 | 14.7% | -3.1% | -2.3% | -1.3% | 0.42 | 2.63 | -22.2 |
| 30 Sept 2024 | Q3 | 22.0% | 5.9% | 5.7% | 2.9% | 0.49 | 2.41 | 18.8 |
| 30 Jun 2024 | Q2 | 17.6% | 1.3% | 1.5% | 0.6% | 0.61 | 2.00 | 37.1 |
| 31 Mar 2024 | Q1 | 13.5% | -7.6% | -8.4% | -3.4% | 0.69 | 1.79 | -7.2 |
| 31 Dec 2023 | Q4 | 13.0% | -6.8% | -7.1% | -2.9% | 0.63 | 1.73 | -9.0 |